Q32 Bio Inc. (QTTB) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -6.34M | -6.18M | -4.23M | -10.65M | -12.48M | -11.43M | -19.52M | -22.21M | -14.55M | -10.71M | 15.9M | 2.19M |
| Operating CF Margin % | - | -11.5% | - | - | - | - | - | - | - | 73.08% | 855.35% | 68.36% |
| Operating CF Growth % | 49.18% | 45.92% | 78.33% | 52.05% | 14.22% | -6.65% | -222.77% | -1113.87% | -16.45% | -212.55% | 163.78% | 107.1% |
| Net Income | -7.61M | 0 | -7.39M | -9.49M | -11.03M | -14.19M | -17.59M | -16.98M | 1.03M | -27.07M | -14.03M | -5.81M |
| Depreciation & Amortization | 33K | 0 | 91K | 91K | 119K | 120K | 123K | 121K | 123K | 124K | 124K | 124K |
| Stock-Based Compensation | 1.55M | 0 | 1.18M | 1.27M | 1.34M | 1.25M | 1.38M | 1.34M | 417K | 0 | 301K | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 253K | -5.99M | 204K | 790K | -687K | 416K | -153K | 63K | -15.54M | 1.89M | 6.4M | 16.94M |
| Working Capital Changes | -568K | -190K | 1.69M | -3.31M | -2.23M | 974K | -3.28M | -6.76M | -576K | 14.34M | 23.11M | -9.06M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -226K | -94K | 63K | -1.8M | -277K | 1.73M | -1.23M | -2.48M | 928K | 1.64M | 1.13M | -3.22M |
| Cash from Investing | 0 | 7M | 0 | 0 | 0 | -2K | 9.94M | 9.89M | 97K | 0 | -1K | -31.38M |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | -2K | -58K | -15K | 0 | 0 | -1K | 224K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | 0.05% | 6.99% |
| Acquisitions | 0 | 7M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 8.8M | -1.56M | -1.56M | 0 | 0 | 317K | 997K | -5.52M | 99.35M | 76K | 300K | -120K |
| Debt Issued (Net) | -1.56M | -1.56M | -1.56M | 0 | 0 | 0 | 0 | 0 | 7M | 0 | 300K | 0 |
| Equity Issued (Net) | 10.36M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 42M | 76K | 0 | -120K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 317K | 997K | -5.52M | 50.35M | 0 | 0 | 0 |
| Net Change in Cash | 2.45M | -742K | -5.79M | -10.65M | -12.48M | -11.11M | -8.58M | -17.85M | 84.89M | -3.49M | -47.69M | 37.34M |
| Free Cash Flow | -6.34M | -6.18M | -4.23M | -10.65M | -12.48M | -11.43M | -19.58M | -22.23M | -14.55M | -10.71M | 15.9M | 2.42M |
| FCF Margin % | - | -11.5% | - | - | - | - | - | - | - | 73.08% | 855.3% | 75.35% |
| FCF Growth % | 49.18% | 45.93% | 78.4% | 52.09% | 14.22% | -6.67% | -223.14% | -1020.46% | -16.4% | -212.55% | 163.76% | 107.8% |
| FCF per Share | -0.45 | -0.49 | -0.35 | -0.87 | -1.02 | -0.94 | -1.62 | -1.86 | -1.22 | -3.32 | 4.95 | 0.75 |
| FCF Conversion (FCF/Net Income) | 0.83x | -0.11x | 0.57x | 1.12x | 1.13x | 0.81x | 1.11x | 1.31x | -14.14x | 0.40x | -1.13x | -0.38x |
| Interest Paid | 0 | 0 | 0 | 259K | 247K | 254K | 264K | 0 | 115K | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |